Relmada Therapeutics, Inc.
RLMD
Revenue
682.00
▼-1.17k▼-63.14%
3 Months ChangeAssets
45.82M
▼-9.91M▼-17.78%
3 Months ChangeLiabilities
10.30M
▲2.20M▲27.12%
3 Months ChangeFree Cash Flow
-981.64k
▲1.19M▲54.75%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-07
Form 10-Q
ID: 0001213900-24-066111
2024-05-30
Form 8-K
ID: 0001213900-24-047968
2024-05-08
Form 10-Q
ID: 0001213900-24-040856
2024-03-19
Form 8-K
ID: 0001213900-24-024022
2024-01-11
Form 8-K
ID: 0001213900-24-003000
2024-01-04
Form 8-K
ID: 0001213900-24-000999
2024-01-03
Form 8-K
ID: 0001213900-24-000858
2023-11-08
Form 10-Q
ID: 0001213900-23-084737
2023-11-08
Form 8-K
ID: 0001213900-23-084735
2023-10-11
Form 8-K
ID: 0001013762-23-002985